Medical News

RSS

pSivida achieves milestone in Phase III Iluvien trial, last patient completes two-year follow up visit

pSivida Corp., a leading drug delivery company that has developed two of the only three products approved by the FDA for the long-term, sustained release delivery of drug to treat chronic back of the eye disease, today announced that the last patient in the Phase III clinical trial being conducted by its collaborative partner, Alimera Sciences, for a new treatment for diabetic macular edema (DME) has completed the two-year follow up visit.

15 Oct 2009

Scientists are trying to decipher the chemistry of human odor

Each of the 6.7 billion people on Earth has a signature body odor - the chemical counterpart to fingerprints - and scientists are tracking down those odiferous arches, loops, and whorls in the "human odorprint" for purposes ranging from disease diagnosis to crime prevention. That's the topic of an article in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine.

15 Oct 2009

Genzyme ranked third on the global list for best employers

Genzyme Corporation announced today that scientists have again named the company a top employer in a survey ranking the reputations of biotechnology and pharmaceutical companies. Genzyme is ranked third on the global list of 575 companies, the second consecutive year it has achieved this position. Genzyme placed among the top 10 of all biotechnology and pharmaceutical companies in the world for the seventh year in a row.

15 Oct 2009

Genes to determine which rectal cancer patient can avoid surgical procedure for treatment

A set of 87 genes one day may be used to routinely determine which patients can be successfully treated for advanced rectal cancer without undergoing a surgical procedure, researchers announced at the 2009 Clinical Congress of the American College of Surgeons.

15 Oct 2009

25-year anniversary of the first neonatal cross-species heart transplantation to be celebrated

Monday, October 26, marks the 25-year anniversary of the first neonatal cross-species heart transplant in history. Dr. Leonard Bailey and a team of doctors at Loma Linda University Medical Center transplanted the heart of a baboon into an infant, born with uniformly lethal heart disease and known to the world as "Baby Fae," on October 26, 1984.

15 Oct 2009

PIKAMAB obtains U.S. patent rights to develop theragnostic product

PIKAMAB, a stratified medicine biopharmaceutical company, announced today that it has secured exclusive rights to two issued U.S. patents from Hospital for Special Surgery, New York. PIKAMAB is developing Lupus TherasightTM, a novel theragnostic product that will eventually help guide the drug development process and patient treatment protocols in the areas of lupus and lupus nephritis.

15 Oct 2009

Resveratrol in red grapes offers some protection against diabetes

A naturally produced molecule called resveratrol, found in the skin of red grapes, has been shown to lower insulin levels in mice when injected directly into the brain, even when the animals ate a high-fat diet.

15 Oct 2009

DNA Link to provide NimbleGen Sequence Capture service in Korea

Roche NimbleGen, a Roche Company, has announced the first Certified Service Provider (CSP), DNA Link, Inc., who will provide service in Korea for NimbleGen Titanium Optimized Sequence Capture coupled with services from 454 Life Sciences, Roche´s center of excellence for sequencing.

15 Oct 2009

Phonak issued with a fine by the German competition authority

Phonak GmbH, the German subsidiary of Switzerland’s Sonova Holding AG (SIX:SOON), has today been issued with a fine by the German competition authority (BKA) following inquiries undertaken by the latter as part of an investigation into the German hearing systems market. Despite the allegations, Sonova was able to reach an agreement with the German Federal Cartel Office and will not appeal against the decision.

15 Oct 2009

Patients with severe cases of the H1N1 virus are at risk for developing severe complications

University of Michigan researchers have found that patients with severe cases of the H1N1 virus are at risk for developing severe complications, including pulmonary emboli, according to a study published today in the American Journal of Roentgenology.

15 Oct 2009

Blue and red colored fabrics offer better protection against UV rays

Economy-minded consumers who want protection from the sun's harmful ultraviolet (UV) rays - but rather not pay premium prices for sun-protective clothing - should think blue and red, rather than yellow.

15 Oct 2009

"A Stroke of Health" for the weight loss benefits of healthy eating

Friday the 13th in June 2008 started out as a normal day for Bob and Judi Swartz, but the day would end as anything but ordinary. Bob would suffer a serious stroke and Judi would take the first steps in a year-long journey of recovery and discovery.

15 Oct 2009

Research to investigate and improve patient adherence to prescription drug therapies

CVS Caremark is sponsoring research to investigate patient adherence to prescription drug therapies and identify ways to increase adherence. Working with researchers from Harvard and Brigham and Women's Hospital, the company expects knowledge gained from the research will help health professionals better understand patient behavior and lead to developing programs that health care providers and pharmacies can use to improve medication adherence and ultimately help improve patient care and medical outcomes by avoiding costly hospital treatment.

15 Oct 2009

New maintenance medium for human embryonic and pluripotent stem cells

STEMCELL Technologies Inc. (STEMCELL) is pleased to announce the release of TeSR™2, a defined, animal-protein free maintenance medium for human embryonic and induced pluripotent stem cells. This medium takes a step towards addressing the needs of researchers working towards the culture of their cells in a medium free of animal-derived proteins.

15 Oct 2009

Phase Forward and Merck project wins the Society for Clinical Data Management Data Driven Innovation Award

Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced that a joint project with customer Merck & Co. has won the 2009 Society for Clinical Data Management (SCDM) Data Driven Innovation Award competition. This annual honor recognizes the year’s best advancement in clinical data management technology or service.

15 Oct 2009

Survey reports patients' concern about the safety and access to flu vaccines

Although some parents may be lukewarm to the H1N1 vaccination, Lakeside Community Healthcare www.LakesideCommunityHealthcare.com, one of Southern California's largest integrated, comprehensive healthcare organizations, reports broader patient concern about both the safety of and access to the vaccine.

15 Oct 2009

Health reform bill approved by finance panel, Snowe sides with Democrats

Kaiser Health News staff writers Eric Pianin and Mary Agnes Carey report on yesterday's Senate Finance Committee action.

15 Oct 2009

Pervasive Integration provides cost-effective data integration solution to healthcare companies

Pervasive Software Inc., a global value leader in embeddable data management and agile data integration software, is providing the flexible, cost-effective data integration required for challenging, increasingly regulated healthcare IT environments.

15 Oct 2009

BioTech Medics' SHBAN Hand Sanitizer Solution kills H1N1 Influenza A virus

BioTech Medics, Inc. announces that it has received independent clinical testing results of its SHBAN™ Hand Sanitizer Solution to prove SHBAN™ kills the H1N1 (Swine) Influenza A virus.

15 Oct 2009

Somanetics obtains exclusive sublicense to new cerebral autoregulation technology

Somanetics Corporation today announced that it has signed an Exclusive Sublicense Agreement with Raba Equity Partners II, LLC ("Raba coreFoundry"). Under terms of the agreement, Somanetics has obtained exclusive rights, subject to specified rights of the U.S. Government and rights retained by The Johns Hopkins University, to new cerebral autoregulation technology developed at The Johns Hopkins University.

15 Oct 2009

Medical News

pSivida achieves milestone in Phase III Iluvien trial, last patient completes two-year follow up visit

Scientists are trying to decipher the chemistry of human odor

Genzyme ranked third on the global list for best employers

Genes to determine which rectal cancer patient can avoid surgical procedure for treatment

25-year anniversary of the first neonatal cross-species heart transplantation to be celebrated

PIKAMAB obtains U.S. patent rights to develop theragnostic product

Resveratrol in red grapes offers some protection against diabetes

DNA Link to provide NimbleGen Sequence Capture service in Korea

Phonak issued with a fine by the German competition authority

Patients with severe cases of the H1N1 virus are at risk for developing severe complications

Blue and red colored fabrics offer better protection against UV rays

"A Stroke of Health" for the weight loss benefits of healthy eating

Research to investigate and improve patient adherence to prescription drug therapies

New maintenance medium for human embryonic and pluripotent stem cells

Phase Forward and Merck project wins the Society for Clinical Data Management Data Driven Innovation Award

Survey reports patients' concern about the safety and access to flu vaccines

Health reform bill approved by finance panel, Snowe sides with Democrats

Pervasive Integration provides cost-effective data integration solution to healthcare companies

BioTech Medics' SHBAN Hand Sanitizer Solution kills H1N1 Influenza A virus

Somanetics obtains exclusive sublicense to new cerebral autoregulation technology

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Latest News